MicroMedicine™ announced the initial steps of a collaboration with HemaCare®. MicroMedicine and HemaCare are uniquely equipped to address the growing need in the cellular therapy and regenerative medicine fields for high-quality starting materials. Specifically, this relationship will help MicroMedicine accelerate the application of microfluidics in processing enriched leukapheresis product collected from peripheral blood. These products are highly valued as inputs in research and therapeutic applications particularly in the world of cellular therapies.